Microcautery for the Treatment of Spider Leg Veins

NCT ID: NCT04072172

Last Updated: 2019-09-11

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 20 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2019-09-01
• Study Completion Date: 2020-10-31

Brief Summary

To Evaluate the role of micro-cauterization use in the treatment and disappearance of spider leg veins.

Detailed Description

Spider veins on the lower limbs are very common and have been reported to be presented in 41% of women over 50 years old. Sclerotherapy as a traditional treatment for spider veins has a low cost, though it may have adverse sequelae. Lasers have shown fewer but still substantial complications as well.1 Spider veins are small superficial veins that widen and become visible, often on the legs and most cutaneous spider veins are abnormalities of the horizontal vascular skin plexus or capillary loops.2 Spider leg veins are composed of a feeder vessel and ectatic venous sprouts in the reticular dermis. Their depth is between 180 µm and 1 mm in the skin.3 Spider veins may have a diameter that reaches several millimetres and can be blue, purple or red and may appear in the form of thin lines, webs or branches.4 There is a scarce available data from literature about the role of micro-cauterization in the treatment of spider veins. The micro-cauterization is an alternative in management of spider veins that delivered via Mole Freckle Pen German Technology.4 Cautery is a safe and effective tool for the treatment of superficial and small skin lesions. It is simple, cheap, and requires minimal training and the results are usually satisfactory Technology Specifications with insulated micro steel needle use current: 5V / 1A of 5-speed free adjustment.5 The current study aims to evaluate the role for micro-cauterization in the treatment and disappearance of spider leg veins.

Conditions

Microcautery for Leg Veins

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Female with leg spider veins

Females at the age of 20 to 45 not known diabetics or hypertensive complaining of leg spider veins.

Group Type: EXPERIMENTAL

Mole Freckle Pen

Intervention Type: DEVICE

Insulated micro steel needle use current: 5V / 1A of 5-speed free adjustment.5

Interventions

Mole Freckle Pen

Insulated micro steel needle use current: 5V / 1A of 5-speed free adjustment.5

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• were patients with spider veins of less than 2.0 mm in diameter.

Exclusion Criteria

• were patients with diabetes, anticoagulation therapy and/or patients with a known history of keloids

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 45 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

Assiut University

OTHER

Sponsor Role: lead

Responsible Party

Doaa M. Selim

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Doaa M. Selim, Resident

Role: PRINCIPAL_INVESTIGATOR

Assiut University

Central Contacts

Doaa M. Selim, Resident

Role: CONTACT

Doaamselim@gmail.com

00201009882011

Mohie Selim

Role: CONTACT

Mohieselim2@yahoo.com

00966554716616

Other Identifiers

Micro-cautery for leg veins

Identifier Type: -

Identifier Source: org_study_id